首页> 外文期刊>The Open Hematology Journal >Endothelial Progenitor Cells Significantly Contribute to Vasculatures in Human and Mouse Breast Tumors
【24h】

Endothelial Progenitor Cells Significantly Contribute to Vasculatures in Human and Mouse Breast Tumors

机译:内皮祖细胞显着贡献于人类和小鼠乳腺癌的脉管系统。

获取原文
           

摘要

The development of blood supply is crucial to the growth and progression of breast tumors. However, the contributionand role of endothelial progenitor cells (EPCs) in blood vessel formation in human breast tumors is undefined.Here, we demonstrate for the first time that ~68% of the cells integrated into vasculatures in late stage human breast tumorsexpress CD34 and CD133 (the putative EPC markers). We also demonstrate that metastatic human breast cancer andmouse mammary gland carcinomas (MGCas) aberrantly express granulocyte colony-stimulating factor (G-CSF). Inhibitionof the MGCa-derived G-CSF significantly decreased the numbers of EPCs in circulation and tumor vasculatures, aswell as microvascular density and growth of transplanted MGCa in mice. These results indicate that EPCs may significantlycontribute to blood vessel formation in advanced stage, G-CSF-expressing breast tumors and that patients with GCSF-producing breast tumors may benefit from angiotherapeutic protocols that inhibit G-CSF-mediated neovascularization.
机译:血液供应的发展对于乳腺肿瘤的生长和发展至关重要。然而,内皮祖细胞(EPCs)在人乳腺肿瘤血管形成中的贡献和作用尚不清楚。在此,我们首次证明了晚期人乳腺肿瘤中约有68%的细胞整合入脉管系统表达CD34和CD133。 (推定的EPC标记)。我们还证明转移性人类乳腺癌和小鼠乳腺癌(MGCas)异常表达粒细胞集落刺激因子(G-CSF)。抑制MGCa衍生的G-CSF可以显着降低小鼠体内循环和肿瘤脉管系统中EPC的数量,以及微血管密度和移植的MGCa的生长。这些结果表明,EPCs可能在晚期阶段显着地促进血管形成,表达G-CSF的乳腺肿瘤,而产生GCSF的乳腺肿瘤的患者可能受益于抑制G-CSF介导的新血管形成的血管治疗方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号